Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
about
9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotectionInteraction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling.Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signalingNovel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase.Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart.Bradykinin preconditioning improves therapeutic potential of human endothelial progenitor cells in infarcted myocardiumThe therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease.Genetic models provide unique insight into angiotensin and bradykinin peptides in the extravascular compartment of the heart in vivo.Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced Akt/eNOS phosphorylation and angiogenesisCyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.ACE inhibitors - angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease.Nitric oxide homeostasis as a target for drug additives to cardioplegiaPharmacologic therapeutics for cardiac reperfusion injury.Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling.Comparison of endothelial function improvement estimated with reactive hyperemia index between ramipril and telmisartan in hypertensive patients.Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: a systematic review.Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration.Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cellsThe acute administration of either amiloride or captopril does not prevent endothelial dysfunction induced by ischemia and reperfusion in the human forearm vasculature.B Type natriuretic peptide: a good omen in myocardial ischaemia?A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening.Hemin, a heme oxygenase-1 inducer, restores the attenuated cardioprotective effect of ischemic preconditioning in isolated diabetic rat heart.Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced Akt/eNOS phosphorylation and angiogenesis.
P2860
Q26750797-A2E7000A-565C-4716-B2FE-93AB6EE56CD1Q30444722-81B1E21B-86D7-4A5E-AF76-1A0AA6362D39Q33752527-68D6FC69-723F-4C77-BAC2-08797769187CQ33784439-48FD4224-1911-4EF9-96F2-F8694F4C8F89Q33957346-E298D321-F2B8-4564-8EF4-FAF961ABB3BEQ35061251-BBC1C9A6-D5C8-4503-ADD9-4AADDBDC9F13Q35117065-2BAD3A0B-BF82-45B5-95FB-4DF53FA14F31Q35125969-212FD395-13F6-48FB-A575-41EAA4498561Q35941293-8C4DE27C-36EE-479D-AFAE-D524E732A401Q36144664-854CCBB5-2FD8-4348-BFDD-2D04C8DFBCF4Q36257966-19BDBB37-3D5C-4B7B-A199-4286F958E673Q36726341-3699FEDC-CB06-4ADB-91D8-9C41EE79CBA2Q36814343-ECFD1753-E67F-40DB-9843-E3D2FF3284C0Q36944008-296735E5-992D-4D73-B6A5-D7A24A2C14A5Q37220195-3DEF128A-A951-4770-B6FB-7003EEC92447Q37642900-3F4F5D0F-9653-4631-B4BC-CCEC71ED7FDEQ37744271-47D60CE0-FCD9-4BA0-B5E4-56238B76EF78Q38227381-DED9F78A-304D-4049-9682-1F859FC5BF6EQ38758106-78289351-70A9-4BD6-8A05-83619ED1EB4EQ39345870-5EFFAA92-D846-4D5B-96AA-407575A32580Q42315735-9E1E1979-87E6-4194-8303-1AB92FFB84DCQ42852248-ED999ADF-1915-4EFC-AF17-FDECD1FB6F4FQ43014687-13CD0078-6936-4A82-A0B9-4F2C7F179283Q43263223-442780B6-552C-4095-9784-C906AAA322D0Q44274431-D3ADF4EE-0606-48DB-B006-EFA1A6527C5BQ52675795-B0E9742F-DA5E-47E8-8F0D-0AB68723D77EQ54853045-4C7D864B-8187-41C5-85C5-89C2B9F6884C
P2860
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@ast
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@en
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@nl
type
label
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@ast
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@en
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@nl
prefLabel
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@ast
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@en
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@nl
P2860
P356
P1476
Role of bradykinin in preconditioning and protection of the ischaemic myocardium.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0704548
P407
P577
2002-02-01T00:00:00Z